{
    "ticker": "TMDX",
    "name": "TransMedics Group, Inc.",
    "description": "TransMedics Group, Inc. is a pioneering medical technology company focused on improving the organ transplant process. Founded in 2016, TransMedics has developed the Organ Care System (OCS), an innovative platform designed to preserve and transport organs for transplantation. The OCS allows for the continuous perfusion of donor organs outside the body, thereby maintaining their viability and function during transport. This revolutionary technology aims to significantly increase the number of usable organs and improve patient outcomes in transplant procedures. TransMedics is dedicated to advancing the science of organ transplantation, providing a solution that enhances the efficiency and effectiveness of organ recovery and transplantation. The company\u2019s mission is to transform the way organs are preserved and transported, ultimately addressing the critical shortage of available organs and improving the quality of life for patients in need of transplants. With a strong emphasis on research and development, TransMedics continues to innovate and expand its offerings in the transplant space, positioning itself as a leader in this vital industry.",
    "industry": [
        "Medical Technology",
        "Healthcare"
    ],
    "headquarters": "Andover, Massachusetts, USA",
    "founded": "2016",
    "website": "https://www.transmedics.com",
    "ceo": "W. D. 'Doug' G. B. Wilkins",
    "social_media": {
        "twitter": "https://twitter.com/TransMedics",
        "linkedin": "https://www.linkedin.com/company/transmedics"
    },
    "investor_relations": "https://ir.transmedics.com",
    "key_executives": [
        {
            "name": "W. D. 'Doug' G. B. Wilkins",
            "position": "CEO"
        },
        {
            "name": "James M. McGowan",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Transplant Technology",
            "products": [
                "Organ Care System (OCS) Heart",
                "Organ Care System (OCS) Lung",
                "Organ Care System (OCS) Liver"
            ]
        }
    ],
    "seo": {
        "meta_title": "TransMedics Group, Inc. | Innovating Organ Transplantation",
        "meta_description": "Learn about TransMedics Group, Inc., a leader in organ transplant technology. Explore the revolutionary Organ Care System designed to improve organ viability and patient outcomes.",
        "keywords": [
            "TransMedics",
            "Organ Transplant",
            "Medical Technology",
            "Organ Care System",
            "Healthcare",
            "Transplant Innovation"
        ]
    },
    "faq": [
        {
            "question": "What is TransMedics known for?",
            "answer": "TransMedics is known for its Organ Care System (OCS), which improves the preservation and transport of organs for transplantation."
        },
        {
            "question": "Who is the CEO of TransMedics?",
            "answer": "W. D. 'Doug' G. B. Wilkins is the CEO of TransMedics Group, Inc."
        },
        {
            "question": "Where is TransMedics headquartered?",
            "answer": "TransMedics is headquartered in Andover, Massachusetts, USA."
        },
        {
            "question": "What are TransMedics' main products?",
            "answer": "TransMedics' main products include the Organ Care System for heart, lung, and liver transplants."
        },
        {
            "question": "When was TransMedics founded?",
            "answer": "TransMedics was founded in 2016."
        }
    ],
    "competitors": [
        "ZTS",
        "ISRG"
    ],
    "related_stocks": [
        "AAPL",
        "AMGN",
        "JNJ",
        "PFE"
    ]
}